RNASE4 and prostate carcinoma: IHC analysis of RNASE4 in prostate cancer TMA (Supplementary Fig. 4) revealed that the tissue level of RNASE4 was also positively correlated with histopathological characteristics (Supplementary Table 9) of prostate cancer patients.